Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up

✍ Scribed by Lenart-Lipińska, M.; Matyjaszek-Matuszek, B.; Gernand, W.; Nowakowski, A.; Solski, J.

• Book ID: 121825004
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 494 KB
• Volume: 101
• Category: Article
• ISSN: 0168-8227
• DOI: 10.1016/j.diabres.2013.04.010